Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration (FDA) for an additional indication for Jaypirca (pirtobrutinib) in adults with previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) without a known 17p deletion. The approval enables Jaypirca to be used as a first-line treatment...
VB Spine Receives FDA Breakthrough Device Designation for ScolimiR-3D
VB Spine has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for ScolimiR-3D, an investigational blood-based diagnostic designed to assess the risk of disease progression in patients with adolescent idiopathic scoliosis (AIS). ScolimiR-3D uses a standard blood sample to measure six circulating microRNA...
Immunome Receives FDA IND Clearance for IM-1340 ADC
Immunome has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for IM-1340, an investigational antibody-drug conjugate (ADC) being developed for advanced solid tumours. IM-1340 is designed to target a transport receptor that shows a distinct expression pattern...
Glycomine’s GLM101 Receives FDA Breakthrough Therapy Designation
Glycomine has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for GLM101, an investigational treatment for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG), a rare multisystem disorder with no approved therapies....
Scholar Rock gains FDA approval for ISEMBYLD in SMA
Scholar Rock has received US Food and Drug Administration (FDA) approval for ISEMBYLD (apitegromab-mstn) for the treatment of spinal...
Telix gains FDA approval for Pixclara glioma imaging
(floretyrosine F 18 or 18F-FET), a PET imaging agent designed to support the assessment of gliomas....
Definium Therapeutics Gains FDA Breakthrough Therapy Designation for DT120
Definium Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to DT120 orally disintegrating tablets (ODT), the company’s investigational lysergide-based treatment for major depressive disorder (MDD)....
FDA Approves Zanvastro for Alexander Disease
The US Food and Drug Administration (FDA) has approved Zanvastro (zilganersen) injection for the treatment of Alexander disease in paediatric and adult patients. It is the first FDA-approved treatment for the rare neurological disorder and the first therapy designed to directly reduce the abnormal protein linked to the disease....
Johnson & Johnson Wins FDA Approval for IMAAVY in wAIHA
Johnson & Johnson has received U.S. Food and Drug Administration (FDA) approval for IMAAVY® (nipocalimab-aahu) to treat warm autoimmune haemolytic anaemia (wAIHA) in adults and paediatric patients aged 12 years and older who are currently or previously treated with corticosteroids....
Juniper Biosciences Secures FDA Breakthrough Designation
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Juniper Biosciences’ JBS-003 (18F-fluoromisonidazole, or FMISO) for identifying tumour hypoxia in patients...
